Results
eNauka >
Results >
Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110
| Title: | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 | Authors: | Herbst, Roy S; ...; Andric, Zoran G   ; ...; (broj, koautora 21) |
Issue Date: | 2020 | Publication: | SWISS MEDICAL WEEKLY | ISSN: | 1424-7860 Swiss Medical Weekly Search Idenfier |
Type: | Conference Paper | Collation: | str. 31S-32S | WoS-ID: | 000592781900077 | URI: | https://enauka.gov.rs/handle/123456789/830057 | Project: | F. Hoffmann-La Roche, Ltd.Hoffmann-La Roche | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.